Berberine and Obatoclax Inhibit SARS-Cov-2 Replication in Primary Human Nasal Epithelial Cells In Vitro

Berberine and Obatoclax Inhibit SARS-Cov-2 Replication in Primary Human Nasal Epithelial Cells In Vitro

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged as a new human pathogen in late 2019 and it has infected over 100 million people in less than a year. There is a clear need for effective antiviral drugs to complement current preventive measures, including vaccines. In this study,...

Full description

Bibliographic Details
Main Authors: Finny S. Varghese, Esther van Woudenbergh, Gijs J. Overheul, Marc J. Eleveld, Lisa Kurver, Niels van Heerbeek, Arjan van Laarhoven, Pascal Miesen, Gerco den Hartog, Marien I. de Jonge, Ronald P. van Rij
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Viruses
Subjects:
coronavirus
COVID-19
antiviral compounds
Online Access:https://www.mdpi.com/1999-4915/13/2/282

Internet

https://www.mdpi.com/1999-4915/13/2/282

Similar Items